Iontophoretic delivery of an insulin-mimetic peroxovanadium compound

Rhonda M. Brand, Gina Duensing, Frederick G Hamel

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The element vanadium has been shown to have insulin mimetic properties which gives it potential for use in the management of diabetes. Oral administration of vanadium has resulted in toxic side effects. Recently, a series of more potent vanadium compounds (peroxovanadium) have been synthesized which should be less toxic. However, there is no evidence that these compounds are orally active. Therefore, the feasibility of transporting peroxovanadium by iontophoretically enhanced transdermal delivery has been studied using several different donor conditions. The molecule was successfully delivered cathodally. Flux was linearly related to donor concentration and current density. The use of CaCl2, instead of NaCl as the donor salt significantly increased drug penetration. Transport increased with decreasing buffer concentration. Hairless mouse skin is a reasonable model for peroxovanadium flux across human skin, since penetration across the two membranes was within a factor of two. This work demonstrates that transdermal delivery of peroxovanadium compounds is feasible and that in vivo studies to test its efficacy in regulating blood glucose levels are warranted.

Original languageEnglish (US)
Pages (from-to)115-122
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume146
Issue number1
DOIs
StatePublished - Jan 1 1997

Fingerprint

Vanadium
Poisons
Vanadium Compounds
Insulin
Hairless Mouse
Skin
Oral Administration
Blood Glucose
Buffers
Salts
Membranes
Pharmaceutical Preparations

Keywords

  • Hairless mouse skin
  • Human skin
  • Iontophoresis
  • Peroxovanadium
  • Transdermal drug delivery
  • Vanadium

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Iontophoretic delivery of an insulin-mimetic peroxovanadium compound. / Brand, Rhonda M.; Duensing, Gina; Hamel, Frederick G.

In: International Journal of Pharmaceutics, Vol. 146, No. 1, 01.01.1997, p. 115-122.

Research output: Contribution to journalArticle

@article{00283fd0e7bc4ec79aa60de7c4e8ff92,
title = "Iontophoretic delivery of an insulin-mimetic peroxovanadium compound",
abstract = "The element vanadium has been shown to have insulin mimetic properties which gives it potential for use in the management of diabetes. Oral administration of vanadium has resulted in toxic side effects. Recently, a series of more potent vanadium compounds (peroxovanadium) have been synthesized which should be less toxic. However, there is no evidence that these compounds are orally active. Therefore, the feasibility of transporting peroxovanadium by iontophoretically enhanced transdermal delivery has been studied using several different donor conditions. The molecule was successfully delivered cathodally. Flux was linearly related to donor concentration and current density. The use of CaCl2, instead of NaCl as the donor salt significantly increased drug penetration. Transport increased with decreasing buffer concentration. Hairless mouse skin is a reasonable model for peroxovanadium flux across human skin, since penetration across the two membranes was within a factor of two. This work demonstrates that transdermal delivery of peroxovanadium compounds is feasible and that in vivo studies to test its efficacy in regulating blood glucose levels are warranted.",
keywords = "Hairless mouse skin, Human skin, Iontophoresis, Peroxovanadium, Transdermal drug delivery, Vanadium",
author = "Brand, {Rhonda M.} and Gina Duensing and Hamel, {Frederick G}",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0378-5173(96)04781-3",
language = "English (US)",
volume = "146",
pages = "115--122",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Iontophoretic delivery of an insulin-mimetic peroxovanadium compound

AU - Brand, Rhonda M.

AU - Duensing, Gina

AU - Hamel, Frederick G

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The element vanadium has been shown to have insulin mimetic properties which gives it potential for use in the management of diabetes. Oral administration of vanadium has resulted in toxic side effects. Recently, a series of more potent vanadium compounds (peroxovanadium) have been synthesized which should be less toxic. However, there is no evidence that these compounds are orally active. Therefore, the feasibility of transporting peroxovanadium by iontophoretically enhanced transdermal delivery has been studied using several different donor conditions. The molecule was successfully delivered cathodally. Flux was linearly related to donor concentration and current density. The use of CaCl2, instead of NaCl as the donor salt significantly increased drug penetration. Transport increased with decreasing buffer concentration. Hairless mouse skin is a reasonable model for peroxovanadium flux across human skin, since penetration across the two membranes was within a factor of two. This work demonstrates that transdermal delivery of peroxovanadium compounds is feasible and that in vivo studies to test its efficacy in regulating blood glucose levels are warranted.

AB - The element vanadium has been shown to have insulin mimetic properties which gives it potential for use in the management of diabetes. Oral administration of vanadium has resulted in toxic side effects. Recently, a series of more potent vanadium compounds (peroxovanadium) have been synthesized which should be less toxic. However, there is no evidence that these compounds are orally active. Therefore, the feasibility of transporting peroxovanadium by iontophoretically enhanced transdermal delivery has been studied using several different donor conditions. The molecule was successfully delivered cathodally. Flux was linearly related to donor concentration and current density. The use of CaCl2, instead of NaCl as the donor salt significantly increased drug penetration. Transport increased with decreasing buffer concentration. Hairless mouse skin is a reasonable model for peroxovanadium flux across human skin, since penetration across the two membranes was within a factor of two. This work demonstrates that transdermal delivery of peroxovanadium compounds is feasible and that in vivo studies to test its efficacy in regulating blood glucose levels are warranted.

KW - Hairless mouse skin

KW - Human skin

KW - Iontophoresis

KW - Peroxovanadium

KW - Transdermal drug delivery

KW - Vanadium

UR - http://www.scopus.com/inward/record.url?scp=0031051208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031051208&partnerID=8YFLogxK

U2 - 10.1016/S0378-5173(96)04781-3

DO - 10.1016/S0378-5173(96)04781-3

M3 - Article

VL - 146

SP - 115

EP - 122

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -